Sai Life — 360° view

Sai Life, a company in the Pharmaceuticals industry, reported revenue of ₹659 crore and net profit of ₹98 crore for the September 2026 quarter.

Sai Life (NSE: SAILIFE) closed at ₹1,800.70 on 20 Nov 2026, up 106.0% over the past year. Its market capitalisation is ₹38,279 crore and it trades at 100.2 times earnings.

Share price
₹1,800.70 (20 Nov 2026)
Market cap
₹38,279 Cr (20 Nov 2026)
P/E
100.16 (20 Nov 2026)
Revenue
₹659 Cr (September 2026 quarter)
Net profit
₹98 Cr (September 2026 quarter)
ROCE
19.6% (FY26)
ROE
15.4% (FY26)
Book value
₹127 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,954.80 / ₹783.85 (20 Nov 2026)
1-year return
106.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SAILIFE

Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.